Adenosine A2 Receptor Antagonists

• 

  Subject Areas on Research

  • Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors. 
  • Requirements for T lymphocyte migration in explanted lymph nodes.